Task: Answer the multiple-choice question.
Question: Which drug exhibits a 18.402\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: COc1ccc2cc(C#N)c(SCC(=O)N3CC(=O)Nc4ccccc43)nc2c1
b: Cc1ccccc1-n1c(SCC(=O)N2CCCC2)nnc1-c1ccccn1
c: Cc1ccc(NC(=O)COC(=O)[C@H](C)NC(N)=O)c(C)c1
Answer: b. Cc1ccccc1-n1c(SCC(=O)N2CCCC2)nnc1-c1ccccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1-n1c(SCC(=O)N2CCCC2)nnc1-c1ccccn1
Cc1ccccc1-n1c(SCC(=O)N2CCCC2)nnc1-c1ccccn1
2-[[4-(2-methylphenyl)-5-pyridin-2-yl-1,2,4-triazol-3-yl]sulfanyl]-1-pyrrolidin-1-ylethanone